Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
Clinical trial NCT01362608 · TERMINATED
Trial details
- NCT number
- NCT01362608
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-20
- Primary completion
- 2015-05-19
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.